Business
U.S. Manufacturing Production Rises In August, But Momentum Slowing
U.S. factory production increased for a fourth straight month in August, but the recovery is showing signs of strain, suggesting business investment in equipment could remain depressed through the end of the year as the COVID19 pandemic drags on.
Reserve Bank of India Issues Draft Rupee Interest Rate Derivatives
The proposed Rupee Interest Rate Derivatives (Reserve Bank) Directions, 2020 are aimed at encouraging higher non-resident participation, enhance the role of domestic market makers in the offshore market, improve transparency, and achieve better regulatory...
US Industrial Production Up Modest 0.4% In August
U.S. industrial production slowed to a modest increase of 0.4% in August, far weaker than the strong bounce back recorded in previous months when factories were coming back to life.
Global Stocks Mixed After Wall Street Rises On Dealmaking
Global stock markets were mixed Tuesday after Wall Street rose on a flurry of corporate deals and China's economic activity improved.
Fiat Chrysler Shares Rise After PSA Merger Deal Revision
Milanlisted shares in Fiat Chrysler rose sharply in early trade on Tuesday, after the group and Peugeot maker PSA revised the terms of their planned merger.
UK Jobless Rate Rises For First Time Since COVID-19 Lockdown
Britain's unemployment rate rose for the first time since the coronavirus lockdown began in March but official data published on Tuesday also showed a less severe fall in employment than feared.
Shell Focussed On Turning Around Troubled Australian Operations
Undaunted by hefty writedowns on its Australian gas assets, Royal Dutch Shell sees its liquefied natural gas business and "new energy" acquisitions Down Under as core to its long term plans, the Australian unit's chairman said on Tuesday.
TRESemmé Hair Ad Angers South Africans Still Hurting From Racist Past
Sitting in a hair salon as a stylist braids her natural hair, Sana Sebone recalls a time in 2013 when she worked on a construction site and was told her dreadlocks were too long and represented a hazard.
Wall Street Climbs On Mega Mergers, Vaccine Hopes
Wall Street's major indexes climbed on Monday on a boost from technology stocks while signs of progress in developing a COVID19 vaccine and a spurt of multibillion dollar deals also brightened the mood.
India Bans Onion Exports As Prices Treble in a Month After Rainfall Hits Crops
India is the world’s biggest exporter of onions, a staple of South Asian cooking. Countries such as Bangladesh, Nepal, Malaysia and Sri Lanka rely on Indian shipments.
Delta Raising $6.5 Billion, Backed By Frequent Flyer Program
Delta Air Lines will use its frequent flyer program to back up $6.5 billion in funding as the pandemic continues to buffet air travel.
TCS Becomes Second Indian Firm to Cross Rs 9 Lakh Crore-market Valuation Mark
The stock of the software services firm gained 2.91 per cent to Rs 2,442.80 — its record high — on the BSE.
Oil Gains As Storm Causes U.S. Gulf Production Halts
Oil prices rose on Monday as a tropical storm in the Gulf of Mexico forced companies to evacuate rigs and halt production, but gains were kept in check by wider concerns about excess supply and falling fuel demand.
Novartis Says Beovu Matched Rival Eylea In Visual Acuity In Eye Disease
Novartis on Monday said its eye drug Beovu matched rival Eylea from Regeneron in visual acuity at one year in patients with diabetic macular edema (DME), as the Swiss drugmaker seeks to regain momentum with the drug after early safety stumbles.
Gilead To Buy Cancer Drugmaker Immunomedics For $21 Billion
Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion, a move that will strengthen its cancer portfolio by gaining access to a promising drug, the two companies said in a joint statement on Sunday.
Gilead Nears Deal To Buy Immunomedics For More Than $20 Billion - WSJ
Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the Wall Street Journal reported on Saturday.